Onda M, Tokunaga A, Nishi K, Yoshiyuki T, Shimizu Y, Kiyama T, Mizutani T, Matsukura N, Tanaka N, Yamashita K
First Department of Surgery, Nipon Medical School, Tokyo, Japan.
Jpn J Surg. 1990 May;20(3):269-74. doi: 10.1007/BF02470660.
We examined the localization of epidermal growth factor (EGF) in 185 specimens of primary human gastric cancer using the avidin-biotin peroxidase complex immunohistochemical method on formalin-fixed paraffin-embedded sections. Thirty-four per cent of the gastric cancer specimens were positive for EGF, which was mainly located in the cytoplasm of the cancer cells and occasionally in the stromal cells, but was not detected in non-cancerous gastric epithelium. Moreover, the presence of EGF in gastric cancer was correlated with gastric wall invasion and lymph node metastasis. EGF was found more often in advanced cancers than in early ones (p less than 0.01), and also more often in cancers with lymph node metastasis than in those without (p less than 0.05). The five-year survival of patients with EGF-positive tumors was worse than that of patients with EGF-negative tumors (p less than 0.05). The presence of EGF in human gastric cancer may thus represent higher malignant potential.
我们采用抗生物素蛋白-生物素过氧化物酶复合物免疫组化方法,在福尔马林固定、石蜡包埋的切片上,检测了185例原发性人类胃癌标本中表皮生长因子(EGF)的定位。34%的胃癌标本EGF呈阳性,主要位于癌细胞的细胞质中,偶尔也见于基质细胞,但在非癌性胃上皮中未检测到。此外,胃癌中EGF的存在与胃壁侵犯和淋巴结转移相关。EGF在进展期癌中比早期癌中更常见(p<0.01),在有淋巴结转移的癌中也比无淋巴结转移的癌中更常见(p<0.05)。EGF阳性肿瘤患者的五年生存率低于EGF阴性肿瘤患者(p<0.05)。因此,人类胃癌中EGF的存在可能代表着更高的恶性潜能。